NCT03882489View on ClinicalTrials.gov

Estimation of Effective Dose 95 (ED95) of Intrathecal Isobaric 2-chloroprocaine (2-CP) Based on the Height (cm) of a Patient Undergoing Ambulatory Knee Arthroscopy

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

August 16, 2019

Study Completion Date

August 17, 2019

Conditions
Knee Arthroscopy
Interventions
DRUG

Isobaric 2-chloroprocaine

The doses of isobaric 2-chloroprocaine will be administrated intrathecally and will be adjusted according to the observed responses in the previous subjects.

Trial Locations (1)

1420

Braine-l'Alleud Hospital, Braine-l'Alleud

All Listed Sponsors
collaborator

Hôpital de Braine-l'Alleud

OTHER

lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT03882489 - Estimation of Effective Dose 95 (ED95) of Intrathecal Isobaric 2-chloroprocaine (2-CP) Based on the Height (cm) of a Patient Undergoing Ambulatory Knee Arthroscopy | Biotech Hunter | Biotech Hunter